APTO - Aptose Biosciences GAAP EPS of -$0.11 beats by $0.02 August, 02 2022 04:04 PM Aptose Biosciences Inc. Aptose Biosciences press release ( NASDAQ: APTO ): Q2 GAAP EPS of -$0.11 (vs. -$0.15 Y/Y) beats by $0.02 . Total cash and cash equivalents and investments as of June 30, 2022 were $62.4 million. For further details see: Aptose Biosciences GAAP EPS of -$0.11 beats by $0.02